NIH-funded research R21 grant

Understanding how certain bacteria start protein production without traditional signals

Official title: Mechanism of Translation Initiation on Leaderless mRNAs

Funded at Auburn University at Auburn · NIH-10738789 · Data updated 2026-11-12

This study is looking at how certain types of mRNAs, which don't have the usual signals to start making proteins, are used by bacteria and archaea, especially Mycobacteria, to help us learn more about how these germs work and why some are resistant to antibiotics.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionAuburn University at Auburn
NIH-funded
Lab location1 site (Auburn, UNITED STATES)
Project startNovember 10, 2022
Project endOctober 31, 2025
Funding year2024
Award (this year)$185,290
NIH project number5R21AI169090-02
Project IDNIH-10738789 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with infections caused by Mycobacteria or other bacteria that utilize leaderless mRNAs.

Less likely to help

Patients with infections caused by bacteria that do not utilize leaderless mRNAs may not benefit from this research.

What this research studies

This research investigates the unique process by which leaderless mRNAs, which lack conventional initiation signals, are translated in bacteria and archaea, particularly focusing on Mycobacteria. The study employs advanced single-molecule fluorescence techniques to observe the translation initiation process in real-time, allowing researchers to identify how these mRNAs interact with ribosomes and translation factors. By uncovering the mechanisms behind leaderless translation, the research aims to enhance our understanding of bacterial physiology and antibiotic resistance.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for combating antibiotic resistance in bacterial infections.

How similar studies have gone: While the specific mechanisms of leaderless mRNA translation are less understood, similar approaches in studying bacterial translation have shown promise in other contexts.

Where this research is happening

  • Auburn University at Auburn
    Auburn, United States
    Active

Researchers

  • Principal investigator: Petrov, Alexey — Auburn University at Auburn
  • Study coordinator: Petrov, Alexey

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.